Terms: = Breast cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824 AND Prognosis
4 results:
1. Genetic mutations in HER2-positive breast cancer: possible association with response to trastuzumab therapy.
Zakaria NH; Hashad D; Saied MH; Hegazy N; Elkayal A; Tayae E
Hum Genomics; 2023 May; 17(1):43. PubMed ID: 37202799
[TBL] [Abstract] [Full Text] [Related]
2. Signet Ring Cell Differentiation in Salivary Duct Carcinoma with Rhabdoid Features: Report of Three Cases and Literature Review.
Akaki M; Ishihara A; Nagai K; Naono H; Taguchi K; Yamamoto H; Tanaka H; Kataoka H
Head Neck Pathol; 2021 Mar; 15(1):341-351. PubMed ID: 32488734
[TBL] [Abstract] [Full Text] [Related]
3. Mutations in BRCA1, BRCA2, and PALB2, and a panel of 50 cancer-associated genes in pancreatic ductal adenocarcinoma.
Takeuchi S; Doi M; Ikari N; Yamamoto M; Furukawa T
Sci Rep; 2018 May; 8(1):8105. PubMed ID: 29802286
[TBL] [Abstract] [Full Text] [Related]
4. Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells.
Alimova I; Birks DK; Harris PS; Knipstein JA; Venkataraman S; Marquez VE; Foreman NK; Vibhakar R
Neuro Oncol; 2013 Feb; 15(2):149-60. PubMed ID: 23190500
[TBL] [Abstract] [Full Text] [Related]